“Human Milk Oligosaccharides (HMO’s) are specialized carbohydrates which are naturally prevalent in mother’s milk,” said John R. Garrett, co-CEO, at Glycosyn. “Through our expertise and know-how we have developed technologies which will complement FrieslandCampina’s extensive history and knowledge of infant nutrition ingredients, products, and markets.”
FrieslandCampina Domo is part of FrieslandCampina Ingredients and a worldwide producer of a wide range of ingredients for the infant-, medical-, and cell nutrition markets. Its range of products consists of whey protein concentrates, demineralized whey products, galacto-oligosaccharides, lactose, hydrolysates, encapsulated nutritional oils, and the emerging products which are being developed from the Glycosyn partnership.
FrieslandCampina Domo and U.S.-based Glycosyn have signed a technology and partnership agreement to develop new infant nutrition ingredients. Glycosyn has developed a patented technology for the production of oligosaccharides from lactose. FrieslandCampina Domo will produce and introduce these new ingredients onto the global market.